1. Home
  2. WAT vs CX Comparison

WAT vs CX Comparison

Compare WAT & CX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • CX
  • Stock Information
  • Founded
  • WAT 1958
  • CX 1906
  • Country
  • WAT United States
  • CX Mexico
  • Employees
  • WAT N/A
  • CX N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • CX Building Materials
  • Sector
  • WAT Industrials
  • CX Industrials
  • Exchange
  • WAT Nasdaq
  • CX Nasdaq
  • Market Cap
  • WAT 17.4B
  • CX 14.7B
  • IPO Year
  • WAT 1995
  • CX 1999
  • Fundamental
  • Price
  • WAT $412.54
  • CX $10.43
  • Analyst Decision
  • WAT Buy
  • CX Buy
  • Analyst Count
  • WAT 13
  • CX 7
  • Target Price
  • WAT $379.00
  • CX $10.52
  • AVG Volume (30 Days)
  • WAT 657.5K
  • CX 8.3M
  • Earning Date
  • WAT 11-04-2025
  • CX 10-28-2025
  • Dividend Yield
  • WAT N/A
  • CX 0.83%
  • EPS Growth
  • WAT 3.82
  • CX 231.88
  • EPS
  • WAT 10.88
  • CX 0.09
  • Revenue
  • WAT $3,105,638,000.00
  • CX $15,869,840,000.00
  • Revenue This Year
  • WAT $7.12
  • CX N/A
  • Revenue Next Year
  • WAT $6.22
  • CX N/A
  • P/E Ratio
  • WAT $37.96
  • CX $10.67
  • Revenue Growth
  • WAT 6.90
  • CX N/A
  • 52 Week Low
  • WAT $275.05
  • CX $4.89
  • 52 Week High
  • WAT $423.56
  • CX $10.56
  • Technical
  • Relative Strength Index (RSI)
  • WAT 79.36
  • CX 61.53
  • Support Level
  • WAT $371.57
  • CX $10.00
  • Resistance Level
  • WAT $391.79
  • CX $10.55
  • Average True Range (ATR)
  • WAT 10.05
  • CX 0.27
  • MACD
  • WAT 1.55
  • CX -0.03
  • Stochastic Oscillator
  • WAT 99.18
  • CX 81.60

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

About CX Cemex S.A.B. de C.V. Sponsored ADR

Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.

Share on Social Networks: